ImmuPharma plc (LON:IMM – Get Free Report)’s stock price shot up 83.3% during trading on Thursday . The company traded as high as GBX 2.49 ($0.03) and last traded at GBX 2.20 ($0.03). 33,956,879 shares were traded during mid-day trading, an increase of 417% from the average session volume of 6,568,868 shares. The stock had previously closed at GBX 1.20 ($0.01).
ImmuPharma Stock Up 66.7 %
The firm has a 50 day moving average of GBX 1.36 and a 200 day moving average of GBX 1.63. The firm has a market cap of £8.33 million, a PE ratio of -200.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Stories
- Five stocks we like better than ImmuPharma
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- Stock Analyst Ratings and Canadian Analyst Ratings
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- What is Put Option Volume?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
